Vanguard Group’s Bio Green Med Solution Inc BGMS Stock Holding History

Vanguard Group’s Portfolio BGMS Stock Details BGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-24	Closed	-$30.8K	–	4506
2023 Q3	$30.8K	Hold	24	–	–	﹤0.01%	4461
2023 Q2	$51.2K	Hold	24	–	–	﹤0.01%	4454
2023 Q1	$49.6K	Hold	24	–	–	﹤0.01%	4469
2022 Q4	$58K	Sell	24 -24	-50%	-$88.5K	﹤0.01%	4431
2022 Q3	$250K	Sell	48 -43	-47%	-$218K	﹤0.01%	4380
2022 Q2	$353K	Hold	91	–	–	﹤0.01%	4366
2022 Q1	$998K	Hold	91	–	–	﹤0.01%	4209
2021 Q4	$1.27M	Hold	91	–	–	﹤0.01%	4194
2021 Q3	$1.73M	Hold	91	–	–	﹤0.01%	4105
2021 Q2	$1.94M	Buy	91 +8	+10%	+$198K	﹤0.01%	3969
2021 Q1	$2.13M	Buy	83 +79	+1,975%	+$2.23M	﹤0.01%	3844
2020 Q4	$121K	Buy	+4	New	+$61.2K	﹤0.01%	4127
2020 Q2	–	Sell	-1	Closed	-$41K	–	4081
2020 Q1	$41K	Hold	1	–	–	﹤0.01%	4010
2019 Q4	$71K	Hold	1	–	–	﹤0.01%	4034
2019 Q3	$42K	Hold	1	–	–	﹤0.01%	4094
2019 Q2	$57K	Sell	1 -1	-50%	-$48.5K	﹤0.01%	4097
2019 Q1	$107K	Hold	2	–	–	﹤0.01%	4006
2018 Q4	$69K	Sell	2 -3	-60%	-$235K	﹤0.01%	4039
2018 Q3	$516K	Hold	5	–	–	﹤0.01%	3847
2018 Q2	$529K	Hold	5	–	–	﹤0.01%	3815
2018 Q1	$506K	Hold	5	–	–	﹤0.01%	3782
2017 Q4	$604K	Buy	5 +1	+25%	+$131K	﹤0.01%	3702
2017 Q3	$473K	Buy	4 +3	+300%	+$439K	﹤0.01%	3763
2017 Q2	$146K	Sell	1 -1	-50%	-$361K	﹤0.01%	3947
2017 Q1	$501K	Buy	2 +1	+100%	+$328K	﹤0.01%	3752
2016 Q4	$467K	Hold	1	–	–	﹤0.01%	3744
2016 Q3	$281K	Hold	1	–	–	﹤0.01%	3851
2016 Q2	$380K	Hold	1	–	–	﹤0.01%	3836
2016 Q1	$351K	Hold	1	–	–	﹤0.01%	3857
2015 Q4	$461K	Hold	1	–	–	﹤0.01%	3851
2015 Q3	$449K	Hold	1	–	–	﹤0.01%	3883
2015 Q2	$702K	Hold	1	–	–	﹤0.01%	3764
2015 Q1	$738K	Hold	1	–	–	﹤0.01%	3710
2014 Q4	$475K	Hold	1	–	–	﹤0.01%	3748
2014 Q3	$1.98M	Hold	1	–	–	﹤0.01%	3270
2014 Q2	$1.96M	Hold	1	–	–	﹤0.01%	3270
2014 Q1	$2.21M	Hold	1	–	–	﹤0.01%	3176
2013 Q4	$2.23M	Hold	1	–	–	﹤0.01%	3144
2013 Q3	$2.32M	Buy	+1	New	+$2.83M	﹤0.01%	3079
2013 Q2	–	Hold	0	–	–	–	3307

Other funds holding BGMS

ACM

Altium Capital Management New York $42M AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

McIlrath & Eck Arlington, Washington $1.35B AUM 15.78% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group's BGMS Position: Q4 2023 in Review

Vanguard Group sold out of Bio Green Med Solution Inc (BGMS) in Q4 2023, closing a stake of 24 shares — an estimated $30.8K sold.

Vanguard Group first reported a position in BGMS in Q3 2013 and held it in 39 quarters. The position peaked at $2.32M in Q3 2013. 8 funds tracked by Wall St. Rank hold BGMS as of Q4 2023.

Vanguard Group reported no remaining Bio Green Med Solution Inc position as of Q4 2023 after selling out during the quarter.
Vanguard Group sold 24 Bio Green Med Solution Inc shares in Q4 2023, an estimated $30.8K.
Vanguard Group first reported a position in Bio Green Med Solution Inc in Q3 2013 and held it in 39 quarters.
Vanguard Group's Bio Green Med Solution Inc position peaked at $2.32M in Q3 2013.
8 funds tracked by Wall St. Rank held Bio Green Med Solution Inc as of Q4 2023.

Based on Vanguard Group's 13F filing for Q4 2023, filed 14 Feb 2024.